CYTH Latest Press Releases, Cyclo Therapeutics Inc Corporate News

Releases

0.7206

0.00%

0.0000

All
Financials
Insiders

8-K | Cyclo Therapeutics, Inc.(0000922247)
10/09/2024 04:01
8-K | Cyclo Therapeutics, Inc.(0000922247)
10/08/2024 13:14
8-K | Cyclo Therapeutics, Inc.(0000922247)
09/09/2024 10:29
8-K | Cyclo Therapeutics, Inc.(0000922247)
08/22/2024 05:37
4 | Cyclo Therapeutics, Inc.(0000922247)
08/20/2024 09:51
4 | Cyclo Therapeutics, Inc.(0000922247)
08/20/2024 09:51
4 | Cyclo Therapeutics, Inc.(0000922247)
08/20/2024 09:50
4 | Cyclo Therapeutics, Inc.(0000922247)
08/20/2024 09:50
4 | Cyclo Therapeutics, Inc.(0000922247)
08/20/2024 09:50
4 | Cyclo Therapeutics, Inc.(0000922247)
08/20/2024 09:50
4 | Cyclo Therapeutics, Inc.(0000922247)
08/20/2024 09:49
10-Q | Cyclo Therapeutics, Inc.(0000922247)
08/14/2024 13:29
8-K | Cyclo Therapeutics, Inc.(0000922247)
07/17/2024 10:36
UPLOAD | Cyclo Therapeutics, Inc.(0000922247)
07/03/2024 07:08
CORRESP | Cyclo Therapeutics, Inc.(0000922247)
07/03/2024 07:08
S-8 POS | Cyclo Therapeutics, Inc.(0000922247)
06/28/2024 13:11
S-8 | Cyclo Therapeutics, Inc.(0000922247)
06/28/2024 13:10
8-K | Cyclo Therapeutics, Inc.(0000922247)
06/11/2024 11:20
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:13
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:13
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:13
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:12
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:11
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:11
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:11
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:10
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:10
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:10
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:09
4 | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 13:08
EFFECT | Cyclo Therapeutics, Inc.(0000922247)
06/05/2024 02:05
S-3 | Cyclo Therapeutics, Inc.(0000922247)
05/24/2024 08:07
10-Q | Cyclo Therapeutics, Inc.(0000922247)
05/15/2024 12:06
10-K/A | Cyclo Therapeutics, Inc.(0000922247)
04/29/2024 12:13
10-K | Cyclo Therapeutics, Inc.(0000922247)
03/18/2024 03:02
8-K/A | Cyclo Therapeutics, Inc.(0000922247)
03/04/2024 11:34
4 | Cyclo Therapeutics, Inc.(0000922247)
02/15/2024 11:47
4 | Cyclo Therapeutics, Inc.(0000922247)
02/15/2024 11:46
4 | Cyclo Therapeutics, Inc.(0000922247)
02/15/2024 11:45
4 | Cyclo Therapeutics, Inc.(0000922247)
02/15/2024 11:44
4 | Cyclo Therapeutics, Inc.(0000922247)
02/15/2024 11:43
4 | Cyclo Therapeutics, Inc.(0000922247)
02/15/2024 11:42
4 | Cyclo Therapeutics, Inc.(0000922247)
02/15/2024 11:41
SC 13G/A | Cyclo Therapeutics, Inc.(0000922247)
02/14/2024 09:46
8-K | Cyclo Therapeutics, Inc.(0000922247)
12/26/2023 11:16
CORRESP | Cyclo Therapeutics, Inc.(0000922247)
12/20/2023 12:08
UPLOAD | Cyclo Therapeutics, Inc.(0000922247)
12/20/2023 12:08
8-K | Cyclo Therapeutics, Inc.(0000922247)
12/19/2023 23:10
425 | Cyclo Therapeutics, Inc.(0000922247)
12/18/2023 07:57
4 | Cyclo Therapeutics, Inc.(0000922247)
11/30/2023 04:09

Webull provides the latest Cyclo Therapeutics Inc (CYTH) stock and general news. This information may help you make smarter investment decisions.

About CYTH

Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company’s Trappsol Cyclo, an orphan drug designated product in the United States and Europe, is the subject of four formal clinical trials for Niemann-Pick Disease Type C1, a rare and fatal genetic disease, (NCT02939547, NCT02912793, NCT03893071 and NCT04860960). The Company is also engaged in conducting a Phase 2b clinical trial using Trappsol Cyclo intravenously in early Alzheimer’s disease (NCT05607615) based on encouraging data from an Expanded Access program for Alzheimer’s disease (NCT03624842).